Possible Evidence For Human Transmission Of Alzheimer’s Pathology Amyloid beta pathology in the grey matter and blood vessel walls characteristic of Alzheimer’s disease (AD) and the related cerebral amyloid angiopathy (CAA) is observed in the brains of deceased patients who acquired Creutzfeldt–Jakob disease (CJD) following treatment with prion-contaminated human growth hormone. Although there is no […]

– Global Co-Development and Co-Commercialization Agreement in Alzheimer’s Disease With Novartis’ Phase 1/2a BACE Inhibitor as the Lead – Preventative Treatment Approach Directed at Genetically Predisposed Individuals at Risk of Developing Alzheimer’s Disease; Builds on Amgen’s Genetic Validation Strategy – Global Co-Development Agreement More Rapidly Advances Amgen’s Migraine Programs, Including AMG 334 in Phase 3 […]